Studies on maxindol as an amine uptake inhibitor.
D000818:Animals; D001921:Brain / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D006892:Hydroxydopamines / Q000037:antagonists & inhibitors / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology*; D008297:Male; D008454:Mazindol / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism*; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects / Q000378:metabolism; D011985:Receptors, Serotonin / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism*; D013574:Synaptosomes / Q000378:metabolism; D010133:p-Chloroamphetamine / Q000494:pharmacology
D006892:Hydroxydopamines; D007211:Indoles; D011941:Receptors, Adrenergic; D011985:Receptors, Serotonin; D012701:Serotonin; D010133:p-Chloroamphetamine; D008454:Mazindol; D004298:Dopamine; D009638:Norepinephrine